Profil bibliographique

Naoki Izawa

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

146Publications signalées

1163Citations signalées

1Affiliations récentes

Institutions déclarées

St. Marianna University School of Medicine

Domaines associés

Colorectal Cancer Treatments and StudiesGastric Cancer Management and OutcomesCancer Genomics and DiagnosticsCancer Treatment and PharmacologyLung Cancer Treatments and Mutations

Publications récentes

Accès ouvert 2026 articleOpenAlex

Trifluridine/tipiracil with or without bevacizumab in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: A retrospective observational study

Hiroko Hasegawa, Rin Inamoto, Keiji Sugiyama, Naoki Izawa et autres

0 citationsTherapeutic Advances in Medical Oncology

Accès ouvert 2026 conference-abstractOpenAlex

BAYONET trial: A multicenter phase II trial of staged combination with encorafenib + binimetinib + cetuximab following encorafenib + cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer.

Takeshi Yamada, Yuki Matsubara, Hideaki Bando, Mitsuhiro Furuta et autres

0 citationsJournal of Clinical Oncology

2026 articleOpenAlex

Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens

Kumiko Umemoto, Kazunari Nakahara, Nobuyuki Ohike, Yusuke Satta et autres

0 citationsJournal of Gastroenterology

Accès ouvert 2026 articleOpenAlex

Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer

Yasmine Baca, Joshua Millstein, Jingyuan Wang, John L. Marshall et autres

0 citationsUNC Libraries

Accès ouvert 2026 articleOpenAlex

Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST)

Yosuke Kito, Kentaro Yamazaki, Hirokazu Shoji, Takeshi Yamada et autres

0 citationsEuropean Journal of Cancer

Accès ouvert 2026 articleOpenAlex

Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: a secondary analysis of a randomized clinical trial

Takahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, Mami Hirakawa et autres

0 citationsThe Oncologist

Accès ouvert 2025 articleOpenAlex

Ramucirumab‐containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum‐based chemotherapy: A multicenter observational retrospective study (WJOG13420G)

Yuki Matsubara, Toshiki Masuishi, Waki Hosoda, Hidekazu Hirano et autres

1 citationInternational Journal of Cancer

Accès ouvert 2025 articleOpenAlex

A multicenter Phase II study of mFOLFOX6 plus nivolumab for gastric cancer with severe peritoneal metastases: WJOG16322G

Munehiro Wakabayashi, Toshiki Masuishi, Takatsugu Ogata, Fumiyasu Hanamura et autres

3 citationsFuture Oncology

Accès ouvert 2025 articleOpenAlex

Prospective Cohort Study of Trastuzumab Biosimilar CT-P6 in HER2-Positive Gastric Cancer: Japanese Real-World Outcomes

Hiroya Taniguchi, Kiyohiro Nishikawa, Naoki Izawa, Hiroshi Imamura et autres

1 citationOncology and Therapy

Accès ouvert 2025 erratumOpenAlex

Erratum: Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

Jun Hamano, Takahiro Higashibata, Takaomi Kessoku, Shinya Kajiura et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2025 articleOpenAlex

Identifying reversible psychiatric dementia mimics in new memory clinic outpatients

Michitaka Funayama, Shin Kurose, Taketo Takata, Hiroyo Sato et autres

2 citationsJournal of Alzheimer s Disease Reports

Accès ouvert 2025 conference-abstractOpenAlex

Phase 1b study of futibatinib plus pembrolizumab in patients with esophageal carcinoma: Evaluating the immunological effects.

Takashi Kojima, Hajime Shinohara, Susumu Eguchi, Naoki Izawa et autres

0 citationsJournal of Clinical Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.